Literature DB >> 16780682

[Enhancement of all-trans retinoic acid-induced differentiation by bufalin in primary culture of acute promyelocytic leukemia cells].

Zhi-tu Zhu1, Bo Jin, Yun-peng Liu, Ying-chun Li, Xiang-lan Lu, Xin Tian, Ke-zuo Hou.   

Abstract

OBJECTIVE: To investigate the effect of bufalin combined with all-trans retinoic acid-induced (ATRA) differentiation of acute promyelocytic leukemia (APL) cells in primary culture.
METHODS: Fresh leukemia cells were obtained from heparinized bone marrow aspirations of 12 newly diagnosed APL patients. Cell viability was determined by trypan blue dye exclusion. Apoptosis of APL cell was assessed by morphological analysis. Differentiation of APL cell was also assessed by morphological analysis. Nitro blue tetrazolium (NBT) reduction test and expression of the granulocyte/macrophage-specific antigen CD(11)b was carried out with flow cytometric assay.
RESULTS: Bufalin combined with ATRA can induce differentiation of APL cells towards mature stages, NBT reduction was increased 15% - 52% and CD(11)b expression was also increased 16% - 69% in combination of bufalin and ATRA as compared with that of ATRA alone, while the concentration of ATRA needed in the combination group was reduced to 30% and the time of differentiation was reduced from 7 days to 4 days.
CONCLUSION: The combination of ATRA with bufalin can significantly enhance the differentiation of acute promyelocytic leukemia cells in primary culture by ATRA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16780682

Source DB:  PubMed          Journal:  Zhonghua Nei Ke Za Zhi        ISSN: 0578-1426


  4 in total

Review 1.  Angel of human health: current research updates in toad medicine.

Authors:  Qian Yang; Xuanxuan Zhou; Meng Zhang; Linlin Bi; Shan Miao; Wei Cao; Yanhua Xie; Jiyuan Sun; Haifeng Tang; Ying Li; Qing Miao; Siwang Wang
Journal:  Am J Transl Res       Date:  2015-01-15       Impact factor: 4.060

2.  Down-regulation of Cbl-b by bufalin results in up-regulation of DR4/DR5 and sensitization of TRAIL-induced apoptosis in breast cancer cells.

Authors:  Shunchao Yan; Xiujuan Qu; Chong'an Xu; Zhitu Zhu; Lingyun Zhang; Ling Xu; Na Song; Yuee Teng; Yunpeng Liu
Journal:  J Cancer Res Clin Oncol       Date:  2012-03-24       Impact factor: 4.553

3.  Anti-tumor activities and apoptosis-regulated mechanisms of bufalin on the orthotopic transplantation tumor model of human hepatocellular carcinoma in nude mice.

Authors:  Ke-Qi Han; Guang Huang; Wei Gu; Yong-Hua Su; Xue-Qiang Huang; Chang-Quan Ling
Journal:  World J Gastroenterol       Date:  2007-06-28       Impact factor: 5.742

4.  Bufalin suppresses the migration and invasion of prostate cancer cells through HOTAIR, the sponge of miR-520b.

Authors:  Jian-Jun Zhang; Xiao-Hui Zhou; Yan Zhou; Yong-Gang Wang; Bin-Zhi Qian; Ai-Na He; Zan Shen; Hai-Yan Hu; Yang Yao
Journal:  Acta Pharmacol Sin       Date:  2019-04-26       Impact factor: 6.150

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.